Tourmaline Bio, Inc.
TRML
$12.62
-$0.21-1.64%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -10.20% | -15.38% | -31.37% | -3.17% | -130.76% |
| Total Depreciation and Amortization | -10.00% | 0.00% | 0.00% | -9.09% | 22.22% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 54.40% | 13.08% | -364.36% | -94.97% | 409.69% |
| Change in Net Operating Assets | 153.92% | -8,521.21% | 98.18% | -814.14% | 63.80% |
| Cash from Operations | 10.90% | -30.19% | -20.67% | -59.55% | -73.33% |
| Capital Expenditure | -- | -- | -- | -- | 88.24% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 240.22% | -15.44% | 94.64% | -4,947.77% | -- |
| Cash from Investing | 240.15% | -15.44% | 94.64% | -4,950.26% | 23,005.88% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -100.00% | -- | -- |
| Repurchase of Common Stock | -200.00% | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | 2,110.68% |
| Cash from Financing | -200.00% | -- | -100.00% | 136.79% | 1,980.82% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 87.19% | -24.88% | 33.70% | -167.71% | 793.70% |
